Skip to main content

CANTOR FITZGERALD, L. P.

Position in IMCR — Immunocore Holdings plc

CIK 1024896 NEW YORK, NY

Position in IMCR

as of Jun 30, 2026 · filed Aug 19, 2026
Position Value
$10,798,175
+$3,254,314 QoQ
Shares Held
340,100
+35.9% QoQ
Ownership
0.660%
of shares outstanding
% of Portfolio
0.22%
of 13F equity value
Holder Rank
#32
of 136 holders
Holding Since
Jun 2024
8 quarters on record
Voting authority Sole 0% Shared 100% None 0%

Common Shares in IMCR Over Time

Shares Held

Position Value (USD)

Derivatives in IMCR

reported options exposure · as of Mar 31, 2026
CallValue
$1,522,575
CallShares
50,500
PutValue
$0
PutShares
0

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Jun 30, 2026

CANTOR FITZGERALD, L. P. holds $32,286,928 across 25 Biotechnology names. IMCR ranks #1 (33.4% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 IMCR
Immunocore Holdings plc
This page
340,100 $10,798,175

All Filings in IMCR

Export CSV
10 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $10,798,175 340,100
2026-03-31 $1,522,575 50,500
2026-03-31 $7,543,861 250,211
2025-12-31 $1,752,855 50,500
2025-09-30 $2,724,750 75,000
2025-06-30 $784,531 25,001
2025-06-30 $2,353,500 75,000
2025-03-31 $2,967,000 100,000
2024-09-30 $3,173,454 101,942
2024-06-30 $8,608,975 254,027